Paper30178490
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?
Eichler HG and 11 others. Clin Pharmacol Ther, 2019. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals? Papers, record 30178490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30178490
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Delivery of Health Care | Major topic |
| Drug Development | Major topic |
| Drug Industry | Major topic |
| Electronic Health Records | Major topic |
| Learning Health System | Major topic |
| Decision Making | |
| Humans | |
| International Cooperation | |
| Randomized Controlled Trials as Topic | |
| Technology Assessment, Biomedical |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29025140 | Policies and strategies to facilitate secondary use of research data in the health sciences. | Int J Epidemiol | 2017 | https://conductscience.org/library/papers/29025140 | PubMed |
| 2 | 23484796 | Dabigatran and postmarketing reports of bleeding. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23484796 | PubMed |
| 3 | 8634569 | Why we need observational studies to evaluate the effectiveness of health care. | BMJ | 1996 | https://conductscience.org/library/papers/8634569 | PubMed |
| 4 | 24616204 | The European Medicines Agency's use of prioritised independent research for best evidence in regulatory action on diclofenac. | Pharmacoepidemiol Drug Saf | 2014 | https://conductscience.org/library/papers/24616204 | PubMed |
| 5 | 14585769 | Evaluating medication effects outside of clinical trials: new-user designs. | Am J Epidemiol | 2003 | https://conductscience.org/library/papers/14585769 | PubMed |
| 6 | 27504911 | Metformin use and risk of lactic acidosis in people with diabetes with and without renal impairment: a cohort study in Denmark and the UK. | Diabet Med | 2017 | https://conductscience.org/library/papers/27504911 | PubMed |
| 7 | 18056625 | Immortal time bias in pharmaco-epidemiology. | Am J Epidemiol | 2008 | https://conductscience.org/library/papers/18056625 | PubMed |
| 8 | 24751815 | Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee. | Nat Rev Drug Discov | 2014 | https://conductscience.org/library/papers/24751815 | PubMed |
| 9 | 29327451 | Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). | Pharmacoepidemiol Drug Saf | 2018 | https://conductscience.org/library/papers/29327451 | PubMed |
| 10 | 25594052 | The combinatorial complexity of cancer precision medicine. | Oncoscience | 2014 | https://conductscience.org/library/papers/25594052 | PubMed |
| 11 | 27650716 | "Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials? | Clin Pharmacol Ther | 2016 | https://conductscience.org/library/papers/27650716 | PubMed |
| 12 | 41224245 | Strengthening Pharmacoepidemiology in a Changing Research Environment: The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). | Pharmacoepidemiol Drug Saf | 2025 | https://conductscience.org/library/papers/41224245 | PubMed |
| 13 | 29159410 | Use of Health Care Databases to Support Supplemental Indications of Approved Medications. | JAMA Intern Med | 2018 | https://conductscience.org/library/papers/29159410 | PubMed |
| 14 | 27049302 | 'You should at least ask'. The expectations, hopes and fears of rare disease patients on large-scale data and biomaterial sharing for genomics research. | Eur J Hum Genet | 2016 | https://conductscience.org/library/papers/27049302 | PubMed |
| 15 | 28912202 | Blockchain Technology: Applications in Health Care. | Circ Cardiovasc Qual Outcomes | 2017 | https://conductscience.org/library/papers/28912202 | PubMed |
| 16 | 29047353 | Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness. | Crit Care | 2017 | https://conductscience.org/library/papers/29047353 | PubMed |
| 17 | 28864726 | From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28864726 | PubMed |
| 18 | 21720406 | Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response. | Nat Rev Drug Discov | 2011 | https://conductscience.org/library/papers/21720406 | PubMed |
| 19 | 20681003 | A basic study design for expedited safety signal evaluation based on electronic healthcare data. | Pharmacoepidemiol Drug Saf | 2010 | https://conductscience.org/library/papers/20681003 | PubMed |
| 20 | 26883990 | Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. | Nat Commun | 2016 | https://conductscience.org/library/papers/26883990 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41742923 | Advancing Decision Support Systems with Data, Informatics, and Learning Health Systems in a Post-Meaningful Use Era. | Mo Med | 2026 | https://conductscience.org/library/papers/41742923 | PubMed |
| 41097687 | Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41097687 | PubMed |
| 40408373 | Evaluating the effectiveness of data governance frameworks in ensuring security and privacy of healthcare data: A quantitative analysis of ISO standards, GDPR, and HIPAA in blockchain technology. | PLoS One | 2025 | https://conductscience.org/library/papers/40408373 | PubMed |
| 39331958 | User Requirements for an Electronic Patient Recruitment System: Semistructured Interview Analysis After First Implementation in 3 German University Hospitals. | JMIR Hum Factors | 2024 | https://conductscience.org/library/papers/39331958 | PubMed |
| 38249849 | Learning healthcare systems in cardiology: A qualitative interview study on ethical dilemmas of a learning healthcare system. | Learn Health Syst | 2024 | https://conductscience.org/library/papers/38249849 | PubMed |
| 38239190 | Current trends and future prospects of drug repositioning in gastrointestinal oncology. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38239190 | PubMed |
| 38186562 | High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic Kidney Disease: A Clinical Research Protocol. | Can J Kidney Health Dis | 2024 | https://conductscience.org/library/papers/38186562 | PubMed |
| 36401303 | How can artificial intelligence optimize value-based contracting? | J Pharm Policy Pract | 2022 | https://conductscience.org/library/papers/36401303 | PubMed |
| 36091761 | How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36091761 | PubMed |
| 35970673 | Translating periodontal data to knowledge in a learning health system. | J Am Dent Assoc | 2022 | https://conductscience.org/library/papers/35970673 | PubMed |
| 35677639 | Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy. | Clin Ophthalmol | 2022 | https://conductscience.org/library/papers/35677639 | PubMed |
| 35502197 | Mapping Outcomes and Registries Used in Current Danish Pharmacoepidemiological Research. | Clin Epidemiol | 2022 | https://conductscience.org/library/papers/35502197 | PubMed |
| 35444533 | Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35444533 | PubMed |
| 35397194 | A vision for integrated publicly available information on regulated medical products. | Clin Transl Sci | 2022 | https://conductscience.org/library/papers/35397194 | PubMed |
| 35325976 | [Research advances of real world study in the field of chronic wound]. | Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi | 2022 | https://conductscience.org/library/papers/35325976 | PubMed |
| 35298789 | Real-World Effectiveness, Tolerability and Safety of Cyclosporine A 0.1% Cationic Emulsion in Severe Keratitis and Dry Eye Treatment. | Ophthalmol Ther | 2022 | https://conductscience.org/library/papers/35298789 | PubMed |
| 35230148 | Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain. | J Ocul Pharmacol Ther | 2022 | https://conductscience.org/library/papers/35230148 | PubMed |
| 35099393 | Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study. | JMIR Med Inform | 2022 | https://conductscience.org/library/papers/35099393 | PubMed |
| 34867312 | A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy Challenges. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34867312 | PubMed |
| 34789314 | Evaluating Diuretics in Normal Care (EVIDENCE): protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertension. | Trials | 2021 | https://conductscience.org/library/papers/34789314 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| F8 | 2157 | PubTator's text mining | https://conductscience.org/library/genes/2157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30178490
GET https://conductscience.org/api/papers/v1/30178490/references?page=2